Haloperidol
CAS 52-86-8
Visão geral
Haloperidol, sold under the brand name Haldol among others, is a typical antipsychotic medication. Haloperidol is used in the treatment of schizophrenia, tics in Tourette syndrome, mania in bipolar disorder, delirium, agitation, acute psychosis, and hallucinations in alcohol withdrawal
A Anant Labs fabrica e fornece impurezas de Haloperidol de alta qualidade para o mercado global. Nossas impurezas EP de Haloperidol são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Dados Técnicos
CAS52-86-8
Fórmula Mol.C21H23ClFNO2
Peso Mol.375.871 g/mol
IUPAC4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
SMILESC1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
InChIInChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2
Chave InChILNEPOXFFQSENCJ-UHFFFAOYSA-N
Sinônimos
haloperidol52-86-8SerenaceAloperidinEukystolSerenaseSerenelfiLintonBrotoponDozicEinalon SAloperidoloGaloperidolHalopoidolHalopalKeselanUlcolindUliolindPernoxSernasSernelAldoBioperidoloSigaperidolPelucesHalostenHaldol Solutab4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-oneHaloperidolumFortunanMcN-JR-1625R-16254-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-oneR 16254-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone1-(3-p-Fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidineDTXSID40341504-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone4'-Fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenoneNSC-170973NSC-615296J6292F8L3DNSC1709734-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-CHEBI:5613DTXCID20141504'-Fluoro-4-(4-hydroxy-4-p-chlorophenylpiperidino)butyrophenone4-(4-(para-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenonegamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorbutyrophenonegamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorobutyrophenoneButyrophenone, 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluoro-1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-VESALIUM COMPONENT HALOPERIDOL4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenonegamma-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-oneButyrophenone, 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro-KentaceKeselenDolpin4'-Fluoro-4-[4-hydroxy-4-(4'-chlorophenyl)piperidino]butyrophenonegamma-[4-(p-chlorophenyl)-4-hydroxypiperidino]-p-fluorobutyrophenone4-[4-(para-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidyl)-1-(4-fluorophenyl)-butan-1-oneRefChem:5876N05AD01200-155-6AloperidolHalojustMixidolLealgin compositumAloperidonMDMO-PPV177716-59-5C21H23ClFNO2MFCD00051423Haloperidol (Haldol)CHEMBL54Haldol (TN)4-(4-Hydroxy-4'-chloro-4-phenylpiperidino)-4'-fluorobutyrophenoneMLS000028450Butyrophenone, 4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-oneNSC615296CAS-52-86-8NCGC00015500-10Aloperidolo [DCIT]HalidolHalopidolPekucesSMR000058303HalolAloperidolo [Italian]S1920Haloperidolum [INN-Latin]NeurodolNSC 170973CCRIS 1630HSDB 3093SR-01000003076EINECS 200-155-6NSC 615296BRN 0331267DuraperidolUNII-J6292F8L3DFortunan;Haloperidol RSEpoxide resin,Haloperidol CRSEpoxy resin;Haldol;Picroside-IIIDozic;Haloperidol, 1Haloperidol, powderPrestwick_250Haloperidol [USAN:USP:INN:BAN:JAN]PS14 - HaloperidolHaloperidol (Standard)Spectrum_000861Tocris-0931starbld0018801Epoxide resin, E-44Opera_ID_446HALOPERIDOL [MI]4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl)Prestwick0_000115Prestwick1_000115Prestwick2_000115Prestwick3_000115Spectrum2_001268Spectrum3_000448Spectrum4_000570Spectrum5_000788HALOPERIDOL [INN]HALOPERIDOL [JAN]Lopac-H-1512HALOPERIDOL [HSDB]HALOPERIDOL [USAN]Biomol-NT_000035GTPL86Probes1_000255Probes2_000296H 1512HALOPERIDOL [VANDF]SCHEMBL8264HALOPERIDOL [MART.]Lopac0_000583Oprea1_509923BSPBio_000130BSPBio_002096HALOPERIDOL [USP-RS]HALOPERIDOL [WHO-DD]HALOPERIDOL [WHO-IP]KBioGR_000980KBioGR_002390KBioSS_001341KBioSS_0023955-21-02-00377 (Beilstein Handbook Reference)MLS001146904BIDD:GT0128DivK1c_000654SPECTRUM1500325SPBio_001236SPBio_0020692-Chloro-4,6-difluorophenlolMcM-JR-1625BPBio1_000144BPBio1_001231orb1311010orb3141230Haloperidol (JP18/USP/INN)Haloperidol - Bio-X trade markBDBM21398Haloperidol, 1mg/ml in MethanolHMS502A16KBio1_000654KBio2_001341KBio2_002390KBio2_003909KBio2_004958KBio2_006477KBio2_007526KBio3_001316KBio3_002869LNEPOXFFQSENCJ-UHFFFAOYSA-HALOPERIDOL [ORANGE BOOK]MSK7134cMAP_000037NINDS_000654AC250GLXC-06536HALOPERIDOL [EP MONOGRAPH]HALOPERIDOL [USP IMPURITY]HMS1568G12HMS1920D03HMS2089M15HMS2091J09HMS2095G12HMS2234P08HMS3261F08HMS3370H11HMS3657I13HMS3712G12HMS5080H05Pharmakon1600-01500325HALOPERIDOL [USP MONOGRAPH]Haloperidol 1.0 mg/ml in MethanolSTR04750L-Threonine-N-fmoc,o-t-butyl etherPTH-L-HISTIDINE HYDROCHLORIDETox21_110162Tox21_300475Tox21_5005834-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenoneCCG-36042CCG-39111EBC-03897HALOPERIDOLUM [WHO-IP LATIN]HY-14538RNSC757054STL417208AKOS000280660Haloperidol for system suitability CRSSamarium(III) acetylacetonate xhydrateTox21_110162_1AT13670CS-1971DB00502FG32041FH23734Haloperidol for peak identification CRSLP00583NSC-757054SDCCGSBI-0050565.P005IDI1_000654MRF-0000027QTL1_000042WLN: T6NTJ A3VR DF& DQ DR DGNCGC00015500-01NCGC00015500-02NCGC00015500-03NCGC00015500-04NCGC00015500-05NCGC00015500-06NCGC00015500-07NCGC00015500-08NCGC00015500-09NCGC00015500-11NCGC00015500-12NCGC00015500-13NCGC00015500-14NCGC00015500-15NCGC00015500-16NCGC00015500-17NCGC00015500-19NCGC00015500-24NCGC00015500-32NCGC00016234-01NCGC00023875-02NCGC00023875-04NCGC00023875-05NCGC00023875-06NCGC00023875-07NCGC00023875-08NCGC00023875-09NCGC00254503-01NCGC00261268-01AC-19691BH166165DA-74000HY-14538SY052276SBI-0050565.P004Haloperidol decanoate impurity, haloperidol-SC 170973AB00052008EU-0100583H0912NS00010402ST50319916SW196557-4C01814D00136H55351M04089VU0239704-10AB00052008-21AB00052008-22AB00052008_23AB00052008_24Haloperidol; Haloperidol Decanoate EP Impurity GL000288Q251347SR-01000003076-2SR-01000003076-8BRD-K67783091-001-04-8BRD-K67783091-001-05-5BRD-K67783091-001-25-3BRD-K67783091-001-26-1BRD-K67783091-003-03-6BRD-K67783091-003-07-7HALOPERIDOL DECANOATE IMPURITY G [EP IMPURITY]SR-01000003076-11Z1590789254Haloperidol, European Pharmacopoeia (EP) Reference Standard.gamma.-[4-(p-Chlorphenyl)-4-hydroxpiperidino]-p-fluorbutyrophenoneHALOPERIDOL DECANOATE IMPURITY, HALOPERIDOL- [USP IMPURITY]Haloperidol, United States Pharmacopeia (USP) Reference Standard.gamma.-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone4-[4-(4-chlorophenyl)-4-hydroxypiperidyl]-1-(4-fluorophenyl)butan-1-oneHaloperidol, Pharmaceutical Secondary Standard; Certified Reference Material4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl) -1-butanoneHaloperidol for peak identification, European Pharmacopoeia (EP) Reference StandardHaloperidol for system suitability, European Pharmacopoeia (EP) Reference Standard65111-47-9InChI=1/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2Poly[2-methoxy-5-(3 inverted exclamation marka,7 inverted exclamation marka-dimethyloctyloxy)-1,4-phenylenevinylene]